Nebacumab
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J06BC01
CAS registry number (Chemical Abstracts Service)
0138661-01-5
Therapeutic Category
Immunomodulator
Chemical Name
Immunoglobulin M (human monoclonal HA-1A anti-endotoxin), disulfide with human monoclonal HA-1A kappa-chain, pentameric dimer (WHO)
Foreign Names
- Nebacumabum (Latin)
- Nebacumab (German)
- Nebacumab (French)
- Nebacumab (Spanish)
Generic Names
- Nebacumab (OS: BAN, USAN)
- Nébacumab (OS: DCF)
- Antiendotoxin monoclonal antibody (IS)
- HA-1A (IS)
- Septomonab (IS)
- Xomen-E5 (IS)
Brand Name
- Centoxin
Centocor, Luxembourg
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
